New options for outpatient chemotherapy – the role of oral fluoropyrimidines
- 31 August 2001
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 27 (4), 211-220
- https://doi.org/10.1053/ctrv.2001.0229
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patientsCancer Chemotherapy and Pharmacology, 2000
- Postoperative chemo–endocrine treatment with mitomycin C, tamoxifen, and UFT is effective for patients with premenopausal estrogen receptor–positive stage II breast cancerBreast Cancer Research and Treatment, 1999
- Treatment of Breast CancerNew England Journal of Medicine, 1998
- Treatment decisions in palliative cancer care: Patients' preferences for involvement and doctors' knowledge about itEuropean Journal Of Cancer, 1997
- Development of Treatment for Advanced Colorectal Cancer: Infusional 5-FU and the Role of New AgentsEuropean Journal Of Cancer, 1996
- Phase I trials of uracil-tegafur (UFT) using 5 and 28 day administration schedulesAnti-Cancer Drugs, 1996
- Advanced colorectal carcinoma: redefining the role of oral ftorafurAnti-Cancer Drugs, 1996
- Phase III Study of Bolus Versus Infusion Fluorouracil With or Without Cisplatin in Advanced Colorectal CancerJNCI Journal of the National Cancer Institute, 1996
- Colorectal Cancer: The ChallengeEuropean Journal Of Cancer, 1996
- A study of quality of life in cancer patients receiving palliative chemotherapySocial Science & Medicine, 1992